Drug recalls
Enforcement reports from the FDA's weekly recall database. Recalls are classified by the health hazard the defect presents: Class I where exposure is reasonably likely to cause serious harm or death, Class II where it may cause temporary or reversible harm, and Class III where it is unlikely to cause harm.
17,975 records · source: openFDA Enforcement
All classes 17,975 Class II 14,511 Class I 1,747 Class III 1,715 Not Yet Classified 2
| Class | Reported | Product | Reason | Firm | Status |
|---|---|---|---|---|---|
| Class II | July 10, 2013 | Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Vancomycin 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Methionine/Choline/Inositol/ B-12, Clinical Specialties Compounding Pharmacy, 318 Baston… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Pap 300 mg-phent 10 mg-prost 100 mcg, Clinical Specialties Compounding Pharmacy, 318… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, 318 Baston… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Injection vehicle, 120 ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Test Cyp 50 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharmacy, 318… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 Baston Road,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 Baston Road,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Test cyp 25 mg-Estadiol valerate 15 mg/mL, Clinical Specialties Compounding Pharmacy, 318… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 Baston Road,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Mitomycin 0.04% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Test Cyp 25 mg-e(2) blend 12 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Clinical Specialties Compounding Pharmacy | Terminated |
| Class II | July 10, 2013 | SODIUM CHLORIDE Sodium Chloride Injection, USP, a) Product code 2B1301- 50 mL in Viaflex Container Quad… | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential… | Baxter Healthcare Corp. | Terminated |
| Class II | July 10, 2013 | Metronidazole Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter,… | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential… | Baxter Healthcare Corp. | Terminated |
| Class II | July 10, 2013 | HEPARIN SODIUM IN SODIUM CHLORIDE Heparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 2000 USP… | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential… | Baxter Healthcare Corp. | Terminated |
| Class II | July 10, 2013 | Sodium Chloride 0.9% Sodium Chloride Injection, USP, in MINI-BAG Plus Container, a) 50 mL (NDC… | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential… | Baxter Healthcare Corp. | Terminated |
| Class II | July 10, 2013 | Dextrose 5% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL… | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential… | Baxter Healthcare Corp. | Terminated |
| Class II | July 3, 2013 | Sodium Chloride 0.9% Sodium Chloride Injection, USP, 50 mL Mini-Bag Plus Container, Rx only, distributed… | Labeling Wrong Barcode; It may display wrong product code reflecting 0.9% Sodium Chloride Injection , USP 100 mL in… | Baxter Healthcare Corp. | Terminated |
| Class III | July 3, 2013 | Derma-Smoothe/FS (fluocinolone acetonide) Topical Oil (SCALP OIL), 0.01 %, 118.28 mL (4… | Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine… | Hill Dermaceuticals, Inc. | Terminated |
| Class II | July 3, 2013 | 70% Dextrose Injection USP, 2000 mL, Rx Only, by Hospira, Inc., Lake Forest, IL 60045,… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | INK-EEZE Tattoo Numbing Spray, 2 oz. (59 mL), Active Ingredients: Lidocaine HCl 5%… | Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed… | Indelicare LLC | Terminated |
| Class II | July 3, 2013 | 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira,… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | 0.9% Sodium Chloride Irrigation, USP, 3000 mL, Rx Only, Hospira, Inc., Lake Forest, IL… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | 1.5% Glycine Irrigation, USP, 3000 mL, Rx Only, Hospira, Inc., Lake Forest, IL 60045 NDC… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | Pure-Aid Allergy Relief, Diphenhydramine HCL Caplets, 25 mg, 20 caplets, Exclusively… | Labeling: Not Elsewhere Classified; foil label on immediate blister pack indicates active ingredient as… | Kareway Product Inc | Terminated |
| Class II | July 3, 2013 | INK-EEZE Tattoo Black Label Numbing Spray, a) 0.27 oz. (8 mL), b) 2 oz. (59 mL), No… | Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed… | Indelicare LLC | Terminated |
| Class II | July 3, 2013 | 0.9% Sodium Chloride Injection, USP, Polyolefin Flexible Container, a) 500 mL (NDC… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | 5% Dextrose Injection USP, a) 250 mL (NDC 0409-7922-02), b) 500 mL (NDC 0409-7922-30), by… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | 0.9% Sodium Chloride Injection, USP, a) 50 mL (NDC 0409-7984-13), b) 50 mL (NDC… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | 20% Dextrose Injection, USP, a) 500 mL in 1000 mL Partial-Fill Container (NDC… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class II | July 3, 2013 | SODIUM CHLORIDE 0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake Forest, IL… | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. | Hospira Inc. | Terminated |
| Class III | June 26, 2013 | Sodium Sulfacetamide 10% and Sulfur 5% Lotion, (NDC 42792-102-01), 25 g Manufactured for:… | Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength. | Mission Pharmacal Co | Terminated |
| Class III | June 26, 2013 | Dr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units, Neomycin Sulfate 3.5mg,… | Failed Stability Specifications: Unable to meet shelf life expiry. | Faria Limited LLC dba Sheffield Pharmaceuticals | Terminated |
| Class II | June 26, 2013 | VECURONIUM Bromide for Injection, 10 mg* per vial, *1 mg per mL when reconstituted to 10… | CGMP Deviations: product was not manufactured under current good manufacturing practices which contributed to Failed… | Sagent Pharmaceuticals Inc | Terminated |
| Class II | June 26, 2013 | 0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx… | Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port… | Hospira Inc. | Terminated |
| Class III | June 26, 2013 | HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 16 fl. oz. (473 mL), Rx Only,… | Subpotent; 24 month stability test station | Hi-Tech Pharmacal Co., Inc. | Terminated |
| Class II | June 26, 2013 | Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister… | Failed Dissolution Specification; during stability testing | Teva Pharmaceuticals USA, Inc. | Terminated |
| Class III | June 26, 2013 | Norpace Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a)… | Failed Dissolution Specification | Pfizer Inc | Terminated |
| Class II | June 26, 2013 | Cleocin Phosphate Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage… | Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent… | Pharmacia & Upjohn LLC | Terminated |
| Class II | June 19, 2013 | Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use… | Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a… | Sandoz Incorporated | Terminated |
| Class III | June 19, 2013 | Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in… | Failed Impurities/Degradation Specifications | Actavis | Terminated |
| Class I | June 19, 2013 | MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count… | Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the… | OLAAX International | Terminated |
| Class I | June 19, 2013 | Rugby NATURAL IRON SUPPLEMENT Ferrous Sulfate, 5 gr (325 mg), 100 TABLETS, Mfd for: RUGBY… | Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness) | Advance Pharmaceutical Inc | Terminated |
| Class III | June 19, 2013 | Amoxicillin Amoxicillin for Oral Suspension, USP 400mg/5mL, NDC 0093-4161-78 (75ml) and 0093-4161-73… | Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner… | Teva Pharmaceuticals USA, Inc. | Terminated |
| Class II | June 12, 2013 | CPM / PSE DM Drops, Antihistamine, Cough Suppressant Decongestant, 1 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 34 - 39 KG (Intradialytic Parenteral Nutrition composed of amino acids, dextrose… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Mesehist DM, Antihistamine, Antitussive, Decongestant, 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 15DM/100GFN/5PEH, Antitussive, Expectorant, Nasal Decongestant, Grape Flavor, 4 fl… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Metronidazole Tablets, USP, 500 mg, packaged in a) 10-count tablets per bottle (NDC… | Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications. | Physicians Total Care, Inc. | Terminated |
| Class III | June 12, 2013 | Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30… | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be… | Novartis Consumer Health | Terminated |
| Class II | June 12, 2013 | Fresenius bag 1% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysate solution… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions | Pentec Health | Terminated |
| Class II | June 12, 2013 | NoHist TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Distributed by:… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Cardec Drops,Antihistamine, Nasal Decongestant, 1 fl oz. bottle, OTC, Manufactured for:… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class III | June 12, 2013 | Disulfiram Tablets USP 250 mg, 100 tablet bottle, Rx only, Manufactured for TEVA… | CGMP Deviation; cotton coil is missing in some packaged bottles | Teva Pharmaceuticals USA, Inc. | Terminated |
| Class II | June 12, 2013 | Baxter LL bag 1% Amino Acids w/KCL (Intraperitoneal Parenteral Nutrition - dialysate… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class III | June 12, 2013 | Voltaren 1% Gel, 100 gm tube, Rx only, Dist By: Physicians Total Care, Tulsa OK 74146,… | Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is being initiated because the lot number and… | Physicians Total Care, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 45 - 51 KG (Intraperitoneal Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Poly-Vent IR, Poly-Vent DM Tablets, Expectorant, Nasal Decongestant, 60 count bottle,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Dallergy TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 60 - 69 KG (Intradialytic Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Mesehist WC, Antihistamine, Antitussive, Decongestant, 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 2CPM/15DM/5PEH, Antihistamine, Nasal Decongestant, Fruit Candy Flavor, 16 fl oz.… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Z-Dex Pediatric Drops, Cough Suppressant Decongestant, Expectorant 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 12.5 CPD/120GFN/5PEH, Cough Suppressant, Expectorant, Nasal Decongestant, Berry… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | TL-Hist PD Drops, Antihistamine, Nasal Decongestant,1 fl oz. bottle, OTC, Manufactured… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | TL-DEX DM, Cough Suppressant Decongestant, Expectorant 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | BroveX PSE DM, Antihistamine, Cough Suppressant, Decongestant, 100 count bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class III | June 12, 2013 | Target Up & Up, athlete's foot cream, full prescription strength, terbinafine… | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be… | Novartis Consumer Health | Terminated |
| Class II | June 12, 2013 | Maxifed-G, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: MCR… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Poly-Vent DM Tablets, Cough Suppressant, Expectorant, Nasal Decongestant, 60 count… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | ZoDen PD, Antihistamine, Nasal Decongestant,16 fl oz. bottle, OTC, Manufactured for:… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Baxter LL bag 1% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysate solution… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Proplete 80+ KG (Intraperitoneal Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Baxter Ultrabag 1.5% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysate… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | AMBI 25CPD/200GFN, Antitussive, Expectorant, Berry Vanilla Flavor, 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | BroveX PSB DM LIQUID, Antihistamine, Decongestant, a) 16 fl oz. bottle, OTC, NDC… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | ZoDen DM Drops, Antihistamine,Cough Suppressant, Decongestant, , 1 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 40PSE/400GFN/20DM, Cough Suppressant, Expectorant, Nasal Decongestant, 100 count… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Baxter LL bag 2% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysate solution… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Tri-Dex PE, Antihistamine, Antitussive, Nasal Decongestant, 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | IDPN (Intradialytic Parenteral Nutrition - dialysate solution with added amino acids), a)… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Ryddex G Tablets, Decongestant, Expectorant, 100 count bottle, OTC, Centurion Labs, LLC… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 25DPH/7.5PEH, Antihistamine, Nasal Decongestant, Fruit Candy Flavor, 16 fl oz.… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | TG 40PSE/400GFN Tablets, 1000 count bottle, OTC Manufactured by: TG United, Inc.… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Poly Hist Forte, Nasal Decongestant, Antihistamine, 100 count bottle, OTC, Manufactured… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 12.5 CPD/100GFN/30PSE, Antitussive, Expectorant, Nasal Decongestant, Raspberry… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Trigofen Drops, Antihistamine, Decongestant,1 fl oz. bottle, OTC, Manufactured for:… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class III | June 12, 2013 | Voltaren Gel (diclofenac sodium topical gel) 1%, for topical use only, RX only, a)… | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be… | Novartis Consumer Health | Terminated |
| Class II | June 12, 2013 | AMBI 40PSE/400GFN, 100 tablet bottle, OTC, Manufactured for: AMBI Pharmaceuticals,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Cardec DM Drops, Decongestant, Antihistamine, Antitussive, 1 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class III | June 12, 2013 | Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1% antifungal), a) 12… | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be… | Novartis Consumer Health | Terminated |
| Class II | June 12, 2013 | ED A-HIST TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 3BRM/15DM/30PSE, Antihistamine, Cough Suppressant, Nasal Decongestant, Berry Vanilla… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 70+ KG (Intraperitoneal Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions | Pentec Health | Terminated |
| Class II | June 12, 2013 | Maxifed DM, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: MCR… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 3BRM/30DM/50PSE, Antihistamine, Cough Suppressant, Nasal Decongestant, Berry Vanilla… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Dallergy CHEWABLE TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Lusair Liquid, 1 PINT bottle, OTC, Marketed by: Pernix Therapeutics, Gonzales, LA 70737… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 40 - 44 KG (Intradialytic Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | BROMPHENIRAMINE/PSEUDOEPHEDRINE DM, LIQUID, Antihistamine, Cough Suppressant,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Z-Dex Syrup, Decongestant, Antitussive, Expectorant, 16 fl oz. bottle, OTC, Manufactured… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Baxter LL bag 1.5% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysate solution… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Fludeoxyglucose F 18 Injection USP, 20-200 mCi/mL, Diagnostic - For Intravenous Use Only,… | cGMP Deviation | Petnet Solution Inc | Terminated |
| Class II | June 12, 2013 | CPM / PSE Drops, Antihistamine, Nasal Decongestant, 1 fl oz. bottle, OTC, Manufactured… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 90+ KG (Intraperitoneal Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | BroveX PSE, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for:… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | Proplete 52 - 59 KG (Intradialytic Parenteral Nutrition - dialysate solution with added… | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions. | Pentec Health | Terminated |
| Class II | June 12, 2013 | Trigofen DM Drops, Antihistamine,Cough Suppressant, Decongestant, , 1 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | AMBI 20DM100GFN10PEH, Antitussive, Expectorant, Nasal Decongestant, Grape Flavor, 16 fl… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | BroveX PSB LIQUID, Antihistamine, Decongestant, a) 16 fl oz. bottle, OTC, NDC… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | TL Hist DM, Antihistamine, Decongestant, Cough Suppressant, 16 fl oz. bottle, OTC,… | CGMP Deviations: Products are underdosed or have an incorrect dosage regime. | TG United, Inc. | Terminated |
| Class II | June 12, 2013 | B-Complex 100 mg/mL Injectable, 50 mL vials, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Procaine 1% Injectable, 100 mL and 250 mL vials, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Tri-Mix Injections in 5 mL and 10 mL vials (Alprostadil, Phentolamine and Papaverine),… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Baclofen 500 mcg/mL Injectable, 22 mL vial, Compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Baclofen 1,000 mcg/mL Injectable, 20 mL and 40 mL vial, Compounded by The Compounding… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Methotrexate 25mg/mL Injectable, 10 mL vials, Compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Phosphatidyl Choline 10%, Injectable, 500 mL vial, compounded by The Compounding Shop,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Ascorbic Acid 500 mg/mL Injectable, 100 mL and 500 mL vials, compounded by The… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Lipoic Acid 25 mg/mL Injectable, 100 mL vials, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Betamethasone 6 mg/mL Injectable, 5 mL vial, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Dexpanthenol 200 mg/mL Injectable, 100 mL vial, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Morphine Sulfate 25 mg/mL Injectable, 40 mL vial, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Mitomycin 0.3 mg/mL Injectable, 10 mL vials, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Dexamethasone 10 mg/mL Injectable, 2 mL vial, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | MIC (Methionine, Inositol, and Choline) + B12 25/50/50mg/1000mcg/mL Injectable, 30 mL… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Hydroxyprogesterone 250 mg/mL Injectable, 4 mL, 6 mL,8 mL and 10 mL vials, compounded by… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Avastin 1.25 mg/0.05 mL Injectable, 4 mL vials, Compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Baclofen/Bupivacaine 2,000 mcg/20 mg/mL Injectable, 45 mL vial, Compounded by The… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Praziquantel 56.8 mg, 50 mL vial, compounded by The Compounding Shop, St. Petersburg, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Glutathione 200 mg/mL Injectable, 50 mL vials, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Sodium EDTA 150 mg/mL Injectable, 250 mL vial, compounded by The Compounding Shop, St.… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Methylcobalamin 1,000 mcg/mL Injectable, 50 mL vials, compounded by The Compounding Shop,… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Carnosine 5% Opth drop, 40 mL vial, compounded by The Compounding Shop, St. Petersburg, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | Testosterone Cypionate 200 mg/mL Injectable, 10 mL vials, compounded by The Compounding… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class II | June 12, 2013 | MIC (Methionine, Inositol, and Choline) Injectable, 30 mL vials, compounded by The… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes | THE COMPOUNDING SHOP, INC. | Terminated |
| Class III | June 12, 2013 | Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream 1% Antifungal, Novartis… | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be… | Novartis Consumer Health | Terminated |
| Class II | June 12, 2013 | DOBUTAMINE IN DEXTROSE DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only,… | Lack of Assurance of Sterility: Confirmed report of leaking in the primary container. | Hospira Inc. | Terminated |
| Class II | June 12, 2013 | DIAZEPAM Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA,… | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Hospira Inc. | Terminated |
| Class III | June 12, 2013 | Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals,… | Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009 | Legacy Pharmaceutical Packaging LLC | Terminated |
| Class III | June 5, 2013 | Lisinopril Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for:… | Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label | Aurobindo Pharma USA Inc | Terminated |
| Class II | June 5, 2013 | PGE-1 Inj 20mcg/ml MDV: 5ml, 7ml, 10ml, 20ml Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Super Trimix #1 Inj MDV, 12 ml Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | M.I.C.+B12 Inj MDV: 3x50ml, 4x50 ml 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Vancomycin Opth Soln 25mg/ml PF, 10ml Opthalmic Soln, 10 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Hydroxycobalamin Inj 2500 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only,… | Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly… | Mylan Pharmaceuticals Inc. | Terminated |
| Class II | June 5, 2013 | HCG Inj 500un/ml MDV, 5 ml Subcutaneous, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Tobramycin Opth Soln 14mg/ml, 7ml Opthalmic Soln, 10 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Bimix Inj 30 :1 Syr, 12x1.5 ml syr, 10x1.2 ml syr, 2x2 ml syr, 2x1 ml syr, 12x.05 ml syr… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class III | June 5, 2013 | Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK… | Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected… | Physicians Total Care, Inc. | Terminated |
| Class II | June 5, 2013 | Bimix Inj 30:0.5 MDV, 5 ml syr Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Methylcobalamin Inj 1mg/ml MDV, 10 ml, 15 ml, 20 ml, 30 ml, 4x30 ml Subcutaneous, 90 day… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Vancomycin Opth Soln 30mg/ml PRES, 10ml Opthalmic Soln, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Gentamicin 24mg/60ml Irrigation, 15x60ml Syr Irrigation, 14 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Glutathione 200mg/ml Inj SDV: 3x50ml 14 day expiration, 1x50ml 21 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Hydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml Subcutaneous, 90 day… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Methylcobalamin Inj 5mg/ml MDV: 5 ml, 10 ml, 12 ml, 20 ml Subcutaneous, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Hydroxycobalamin Inj 1 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Meperidine 100mg/ml MDV, 5ml 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Lidocaine 2% Inj MDV, 20 ml 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | PGE-1 Inj 40mcg/ml MDV, 5 ml Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | HCG Inj 1250 un/ml MDV, 4 ml Subcutaneous, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | HCG Inj 1000un/ml MDV: 4ml, 8 ml Subcutaneous, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Folic Acid Inj 5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | PHMB Opth Soln 0.02%, 10 ml Opthalmic Soln, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Chlorhexidine Opth Soln 0.02%, 10 ml Opthalmic Soln, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Trimix Inj 4.25ml Form MDV Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Vancomycin Opth Soln14mg/ml PF, 10ml Opthalmic Soln, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Trimix Inj 30:3:5 MDV, 10ml Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Trimix Inj 30:1:10 MDV, 5 ml Penile Injection, 30 and 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class III | June 5, 2013 | Seasonale(R) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg, 3… | Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during… | Teva Pharmaceuticals USA, Inc. | Terminated |
| Class II | June 5, 2013 | HCG Inj 1200un/ml MDV, 10 ml Subcutaneous, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Papaverine Inj 30mg/ml Syr, 5mlsyr, 10mlsyr,10x0.95mlsyr Penile Injection, 90 day… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Tobramycin Opth Soln 13mg/ml, 7ml Opthalmic Soln, 10 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Methylcobalamin Inj 2.5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | PGE-1 Inj 30mcg/ml MDV, 7 ml Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Pyridoxine 100mg/ml Inj MDV, 1X30 ml 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | PGE-1 Inj 10mcg/ml MDV, 5ml Penile Injection, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Methylcobalamin 5mg/ml Inj Syr, 10x0.4syr Subcutaneous, 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Methylcobalamin Inj 25mg/ml Syr: 8x0.06mlsyr, 10x0.06 ml syr, 12x0.06 ml syr… | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Renacidin Irrigation: 1000 ml,1120ml Bladder Irrigation, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Trimix Inj 30:1:40 MDV, 5 ml Penile Injection, 30 and 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Dexamethasone Opth Soln 0.1% PF, 10 ml Opthalmic Soln, 30 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Trimix Inj 30:1:20 MDV: 5 ml, 10 ml, 2x5 ml Penile Injection, 30 and 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class II | June 5, 2013 | Bimix Inj 30:1 MDV: 5ml, 10 ml, 3x10ml, 2x10ml Penile Injection, 30 and 90 day expiration | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. | Nora Apothecary and Alternative Therapies, Inc. | Terminated |
| Class III | June 5, 2013 | Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl… | Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected… | Teva Pharmaceuticals USA, Inc. | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP) , 125 mcg, RX only, 100 tablets per… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 150 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class III | May 29, 2013 | Budesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x… | Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification… | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.200 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle.… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class III | May 29, 2013 | Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis… | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be… | Novartis Consumer Health | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class III | May 29, 2013 | Rite Aid brand Maximum Strength Tussin Cough & Cold Mucus Relief CF, (dextromethorphan… | Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.… | Aaron Industries Inc | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | LEVOXYL Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles… | Subpotent Drug: The products were below specification for potency at the expiry stability point. | King Legacy, a wholly owned subsidiary of Pfizer | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.100 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle,… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class II | May 29, 2013 | Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet… | cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine… | Lloyd Inc. of Iowa | Terminated |
| Class I | May 22, 2013 | Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only,… | Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection). | Gilead Sciences, Inc. | Terminated |
| Class II | May 22, 2013 | Dexpanthenol Injection, all strengths and all presentations including Dexpanthenol 250… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class I | May 22, 2013 | Mojo Nights, 1 capsule, UPC 7 18122 11983 7, Distributed By: Mojo Health Lauderhill, FL… | Marketed Without an Approved NDA/ANDA: The products were found to contain FDA approved ingredients and analogues of FDA… | Evol Nutrition | Terminated |
| Class II | May 22, 2013 | Magnesium Sulfate Injection, all strengths and all presentations including a) Magnesium… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Methylprednisolone and Dexamethasone Injection, all strengths and all presentations… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Human Chorionic Gonadotropin Injection, all strengths and all presentations including a)… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Methylprednisolone, Lidocaine, and Sodium Chloride Injection, all strengths and all… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Biotin Injection, all strengths and all presentations including Biotin-15-30 mL, Rx only,… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Lipotropic With Vitamins with Methylcobalamin Injections, all strengths and all… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Lipotropic With Vitamin Injections, all strengths and all presentations including a) Lipo… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class I | May 22, 2013 | CASANOVA Capsules, 450 mg, MALE SEXUAL ENHANCER, supplied i n1 count blister packs, UPC… | Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA… | Performance Plus Marketing, Inc. | Terminated |
| Class II | May 22, 2013 | Cyanocobalamin Injection, all strengths and all presentations including a) Cyanocobalamin… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Betamethasone Combination with Lidocaine 1% and Bupivacaine 0.5 % Injection, all… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Ascorbic Acid Injection, all strengths and all presentations including a) 500 mg/mL, b)… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Testosterone Cypionate and Testosterone Propionate Injection, all strengths and all… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Pyridoxine Hydrochloride Injection, all strengths and all presentations including… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Hydrochloric Acid Injection, all strengths and all presentations including a)… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | B-Complex Injection, all strengths and all presentations including a) B-Complex Injection… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Methylprednisolone Acetate and Marcaine Injection, all strengths and all presentations… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Dexamethasone Sodium Phosphate Injection, all strengths and all presentations including… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Bupivacaine Injection, all strengths and all presentations including a) Bupivacaine… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | MIC Vitamin Injection, all strengths and all presentations including a) MIC 25-50-25-30… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class II | May 22, 2013 | Polidocanol Injection, all strengths and all presentations including a) Polidocanol 5% 30… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |
| Class I | May 22, 2013 | libigrow XXXTREME Capsules, MAXIMUM STRENGTH FORMULA, 1000 mg, supplied in 1, 5 and 10… | Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA… | Performance Plus Marketing, Inc. | Terminated |
| Class II | May 22, 2013 | Modified Myers Cocktail Injection, all strengths and all presentations including a) Mod… | Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding… | FVS Holdings, Inc. dba. Green Valley Drugs | Terminated |